Author

D. Llobet-Navas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

L. Devis-Jauregui· 2 shared R. Rodriguez-Barrueco· 2 shared A. Molero-Valenzuela· 1 shared A. Molina-Crespo· 1 shared A. Rojo-Sebastian· 1 shared A. Soriano· 1 shared C. Bernado-Morales· 1 shared C. Gonzalo-Consuegra· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Devis-Jauregui

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Gasdermin B over-expression arbitrates HER2-targeted therapy resistance by inducing protective autophagy

M. Gamez-Chiachio, A. Molina-Crespo, C. Ramos-Nebot, J. Martinez-Val, L. Martinez, K. Gassner, F. J. Llobet, C. Gonzalo-Consuegra, M. Cordani, C. Bernado-Morales, E. Diaz, A. Rojo-Sebastian, J. C. Trivino, L. Sanchez, R. Rodriguez-Barrueco, , G. Moreno-Bueno

This study identifies GSDMB over-expression as a driver of HER2-targeted therapy resistance through autophagy induction and shows that combining lapatinib with chloroquine enhances therapeutic efficacy in GSDMB-positive tumors.

Journal of Experimental & Clinical Cancer Research · Sep 26, 2022Peer-reviewedCancer Biology

Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

C. Jimenez, R. Antonelli, M. Nadal-Ribelles, L. Devis-Jauregui, P. Latorre, C. Sole, M. Masanas, A. Molero-Valenzuela, A. Soriano, J. Sanchez de Toledo, D. Llobet-Navas, J. Roma, F. Posas, E. de Nadal, S. Gallego, , M. F. Segura

This study shows that disrupting the BAF chromatin remodeller in neuroblastoma cells reduces metastasis by repressing an invasiveness-related epigenomic program.

bioRxiv · May 17, 2022Cancer Biology

The miR-424/503 cluster modulates Wnt/β-catenin signaling in the mammary epithelium by regulating the expression of the LRP6 co-receptor

E. A. Nekritz, R. Rodriguez-Barrueco, K.-K. Yan, M. L. Davis, R. L. Werner, L. Devis-Jauregui, P. Mukhopadhyay, J. Yu, D. Llobet-Navas, J. Silva

The paper identifies the miR-424/503 cluster as a regulator of Wnt/β-catenin signaling in mammary epithelium by targeting LRP6, and links its loss to breast cancers with high Wnt/β-catenin activity.

bioRxiv · May 6, 2021 · PreprintCancer Biology